For this reason, the present experiments investigated whether the cannabinoid system influences emotional and cognitive alterations in a model of early PD and whether the CB1 antagonist SR141716A reduces the 6-OHDA damaging effects in depression-like behavior and memory function in rats. Here, CNR1 is linked to depressive disorder.